Leading investment firm invests in new CSIRO health technology
Aug 8, 2019
Next Investors
Aug 8, 2019 |
5 min
The estimated present value of benefits from the CSIRO’s work is around $3.2 billion per year, so it's no surprise that the CSIRO and the rather astute BioScience Managers would eventually cross paths.
